Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 BMC Gastroenterol
1 BMC Surg
7 Br J Surg
2 Endoscopy
1 Gastroenterology
2 Gut
1 Nature
11 Pancreas
5 Pancreatology
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Scand J Gastroenterol
2 Surgery

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Gastroenterol

  1. LIN RT, Chen PL, Yang CY, Yeh CC, et al
    Risk factors related to age at diagnosis of pancreatic cancer: a retrospective cohort pilot study.
    BMC Gastroenterol. 2022;22:243.
    PubMed         Abstract available

    BMC Surg

  2. ZHOU H, Yu S, Wu X, Li X, et al
    Application of purse string suture pancreaticojejunostomy for undilated pancreatic duct in total laparoscopic pancreaticoduodenectomy.
    BMC Surg. 2022;22:195.
    PubMed         Abstract available

    Br J Surg

  3. KEMPENEERS MA, Boermeester MA
    Author response to: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589957. doi: 10.1093.

  4. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours.
    Br J Surg. 2022 May 20. pii: 6589936. doi: 10.1093.
    PubMed         Abstract available

  5. JULIANOV A, Saroglu A
    Comment on: Short- and long-term outcomes of selective use of Frey or extended lateral pancreaticojejunostomy in chronic pancreatitis.
    Br J Surg. 2022 May 20. pii: 6589664. doi: 10.1093.

  6. HEIDSMA CM, Nieveen van Dijkum EJ
    Author response to: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: Nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587120. doi: 10.1093.

  7. WANG X
    Comment on: Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2022 May 17. pii: 6587118. doi: 10.1093.

  8. NICKEL F, Lang F, Kowalewski KF, Haney CM, et al
    Pancreatic surgery with or without drainage: propensity score-matched study.
    Br J Surg. 2022 May 17. pii: 6586613. doi: 10.1093.
    PubMed         Abstract available

  9. DAMANAKIS AI, Toader J, Wahler I, Plum P, et al
    Influence of patient sex on outcomes after pancreatic surgery: multicentre study.
    Br J Surg. 2022 May 16. pii: 6586217. doi: 10.1093.
    PubMed         Abstract available


  10. IWANO K, Toyonaga H, Hayashi T, Kin T, et al
    Tunnel creation method in endoscopic necrosectomy for walled-off pancreatic necrosis.
    Endoscopy. 2022 May 13. doi: 10.1055/a-1816-8065.

  11. IWANO K, Ishii T, Hayashi T, Kin T, et al
    Successful biliary drainage in a patient with a giant hiatal hernia and pancreatic prolapse using the percutaneous-endoscopic rendezvous technique.
    Endoscopy. 2022 May 13. doi: 10.1055/a-1816-7678.


  12. ONNEKINK AM, Boxhoorn L, Timmerhuis HC, Bac ST, et al
    Endoscopic versus surgical step-up approach for infected necrotizing pancreatitis (ExTENSION): long-term follow-up of a randomized trial.
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00504.
    PubMed         Abstract available


  13. ALFARANO G, Audano M, Di Chiaro P, Balestrieri C, et al
    Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells.
    Gut. 2022 May 13. pii: gutjnl-2021-325811. doi: 10.1136/gutjnl-2021-325811.
    PubMed         Abstract available

  14. JANCSO Z, Demcsak A, Sahin-Toth M
    Modelling chronic pancreatitis as a complex genetic disease in mice.
    Gut. 2022 May 16. pii: gutjnl-2022-327601. doi: 10.1136/gutjnl-2022-327601.


  15. LUKSZA M, Sethna ZM, Rojas LA, Lihm J, et al
    Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.
    Nature. 2022 May 19. pii: 10.1038/s41586-022-04735.
    PubMed         Abstract available


  16. WINTER K, Dzieniecka M, Strzelczyk J, Wagrowska-Danilewicz M, et al
    Hedgehog Signaling Pathway Proteins in Prognosis of Pancreatic Ductal Adenocarcinoma and Its Differentiation From Chronic Pancreatitis.
    Pancreas. 2022;51:219-227.
    PubMed         Abstract available

  17. SUZUKI A, Ishii S, Fujisawa T, Saito H, et al
    Efficacy and Safety of Peroral Pancreatoscopy Through the Fistula Created by Endoscopic Ultrasound-Guided Pancreaticogastrostomy.
    Pancreas. 2022;51:228-233.
    PubMed         Abstract available

  18. WYNESS SP, Nelson HA, Jensen R, Bird J, et al
    Clinical and Analytical Characterization of the DiaSorin and ScheBo Fecal Pancreatic Elastase 1 Assays.
    Pancreas. 2022;51:243-249.
    PubMed         Abstract available

  19. BULOW R, Tjaden C, Ittermann T, Hinz U, et al
    Epidemiological Factors Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Dual Center Case-Control Study.
    Pancreas. 2022;51:250-255.
    PubMed         Abstract available

  20. DIKE CR, Sellers ZM, Husain SZ, Forsmark CE, et al
    Multidisciplinary Approach to the Care of Children With Acute Recurrent Pancreatitis and Chronic Pancreatitis.
    Pancreas. 2022;51:256-260.
    PubMed         Abstract available

  21. SCHRADER M, Oberkofler CE, Pietge H, Pavic M, et al
    Stereotactic Irradiation of the Pancreas: Case Study of a Patient With Persistent Pancreatic Fistula.
    Pancreas. 2022;51:e62-e63.

  22. FREITAS M, Lima Capela T, Macedo Silva V, Arieira C, et al
    Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.
    Pancreas. 2022;51:288-294.
    PubMed         Abstract available

  23. LEE S, Maegawa FB, Joseph S, Alvarado LA, et al
    Pancreatic Neuroendocrine Tumors: The Effect of Facility Type on Patient Survival.
    Pancreas. 2022;51:282-287.
    PubMed         Abstract available

  24. IEDE K, Yamada T, Koh M, Ueda M, et al
    Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer.
    Pancreas. 2022;51:278-281.
    PubMed         Abstract available

  25. SUTO H, Okano K, Oshima M, Ando Y, et al
    Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.
    Pancreas. 2022;51:269-277.
    PubMed         Abstract available

  26. IKEDA M, Hamada S, Kikuta K, Takikawa T, et al
    Acute Pancreatitis in Japan: Comparison of Before and After Revision of the Clinical Guidelines.
    Pancreas. 2022;51:261-268.
    PubMed         Abstract available


  27. ZHANG Y, Ma Y, Wang Y, Mukhopadhyay D, et al
    Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth.
    Pancreatology. 2022 Apr 13. pii: S1424-3903(22)00108.
    PubMed         Abstract available

  28. TUCK NL, Teo K, Kuhlmann L, Olesen SS, et al
    Pain patterns in chronic pancreatitis and chronic primary pain.
    Pancreatology. 2022 May 2. pii: S1424-3903(22)00167.
    PubMed         Abstract available

  29. PALATHINGAL BAVA E, George J, Iyer S, Sahay P, et al
    Pirfenidone ameliorates chronic pancreatitis in mouse models through immune and cytokine modulation.
    Pancreatology. 2022 May 7. pii: S1424-3903(22)00169.
    PubMed         Abstract available

  30. RYGIEL AM, Unger LS, Sorgel FL, Masson E, et al
    Variants in the pancreatic CUB and zona pellucida-like domains 1 (CUZD1) gene in early-onset chronic pancreatitis - A possible new susceptibility gene.
    Pancreatology. 2022 May 1. pii: S1424-3903(22)00166.
    PubMed         Abstract available

  31. SIRTL S, Mahajan UM, Auernhammer CJ, Dziadkiewicz P, et al
    Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis.
    Pancreatology. 2022 May 12. pii: S1424-3903(22)00150.
    PubMed         Abstract available

    PLoS One

  32. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  33. Correction for Lebedeva et al., Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas.
    Proc Natl Acad Sci U S A. 2022;119:e2204209119.

    Scand J Gastroenterol

  34. NOJGAARD C, Werge M, Naver A, Wilkens Knudsen A, et al
    Long-term changes of pancreatic function in patients with complicated walled-off necrosis.
    Scand J Gastroenterol. 2022 May 11:1-7. doi: 10.1080/00365521.2022.2072176.
    PubMed         Abstract available


  35. BERGQUIST JR, Shariq OA, Li AY, Worth PJ, et al
    Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
    Surgery. 2022 May 13. pii: S0039-6060(22)00241.
    PubMed         Abstract available

  36. ETHERIDGE JC, Cooke RM, Castillo-Angeles M, Jarman MP, et al
    Disparities in uptake of cholecystectomy for idiopathic pancreatitis: A nationwide retrospective cohort study.
    Surgery. 2022 May 11. pii: S0039-6060(22)00242.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.